Pura Vida Investments, LLC In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Pura Vida Investments, LLC reported 30 stock positions worth $146.8 million . Its top holding was Exact Sciences (EXAS) at 22.7% of the portfolio, followed by Establishment Labs (ESTA, 9.1% ) and Intuitive Surgical (ISRG, 6.5% ). Compared with Q4 2023, it opened 13 new positions, sold out of 8, added to 6 and reduced 9. The biggest buy was a new position in Exact Sciences (EXAS) and the biggest sale an exit from Medavail (MDVLQ).
Location NEW YORK, NY
CIK 0001590144
Portfolio Value $146.8M (Q1 2024) Holdings 30 stocks · $146.8M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q4 2023 EXAS Exact Sciences Corp. 481,910 $33.3M New ESTA Establishment Labs Holdings 261,673 $13.3M Reduce -37.4% ISRG Intuitive Surgical Inc. 24,050 $9.6M New QTRX Quanterix Corp. 375,985 $8.9M Reduce -42.3% LYRA Lyra Therapeutics Inc. 1,413,242 $8.8M No change GKOS Glaukos Corp. 79,000 $7.4M New NTRA Natera Inc. 71,606 $6.5M Reduce -23.0% MSOS Advisorshares Pure US Cann 580,000 $5.8M Add +225.3% LIVN Livanova PLC 90,151 $5.0M Reduce -30.6% MGX Metagenomi Therapeutics Inc. 461,283 $4.9M New ATEC Alphatec Holdings Inc. 320,054 $4.4M Add +4.9% LUNG Pulmonx Corp. 466,787 $4.3M Reduce -2.2% DXCM Dexcom Inc. 30,000 $4.2M Add +14.7% VKTX Viking Therapeutics Inc. 39,868 $3.3M New INSP Inspire Medical Systems Inc. 15,000 $3.2M Add +50.0% ELAN Elanco Animal Health Inc. 193,250 $3.1M Reduce -16.0% SWAV Shockwave Medical Inc. 8,771 $2.9M New RGEN Repligen Corp. 11,225 $2.1M New GH Guardant Health Inc. 100,000 $2.1M Add +566.7% CUTRQ Cutera Inc. 1,078,727 $1.6M Add +0.8% IMDX Insight Molecular Diagnostic filed as ONCOCYTE CORP 523,928 $1.5M Reduce -10.7% TNDM Tandem Diabetes Care Inc. 42,500 $1.5M New EW Edwards Lifesciences Corp. 15,408 $1.5M New TXG 10X Genomics Inc. Class A 38,005 $1.4M New BAX Baxter International Inc. 30,000 $1.3M New ZIMV Zimvie Inc. 73,095 $1.2M New TMCI Treace Medical Concepts Inc. 89,897 $1.2M New NSPR Inspiremd Inc. 450,517 $1.1M No change MYGN Myriad Genetics Inc. 44,725 $954K Reduce -10.6% RCEL Avita Medical Inc. 35,000 $561K Reduce -90.3%
Options reported separately and not counted above: ISHARES TR puts ($148.3M), HUMANA INC calls ($60.7M), STATE STR SPDR S&P 500 ETF T puts ($41.8M), ISHARES TR puts ($38.6M), EXACT SCIENCES CORP calls ($34.2M), SPDR SERIES TRUST puts ($32.3M), INVESCO QQQ TR puts ($26.6M), ARK ETF TR puts ($11.5M), ADVISORSHARES TR calls ($9.5M), LIVANOVA PLC calls ($8.1M), ARK ETF TR puts ($7.5M), GUARDANT HEALTH INC calls ($6.7M), and 6 more.
Other holdings (3): bonds, preferreds, convertibles and warrants · $101K (not counted above) Security Class Shares / Principal Value Change TALKW Hudson Executive Inv -CW25 *W EXP 06/21/202 378,000 $85K No change RCKTW Rocket Pharmaceuticals in-27 *W EXP 09/02/202 42,960 $13K No change MAPSW WM Technology Inc.-CW24 *W EXP 06/16/202 50,000 $3K No change
Total filed on the 13F, all lines: $147.0M.
Portfolio Sells Q4 2023 → Q1 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▲ MDVLQ Medavail Holdings Inc. Sold out 0.00% −78.22 RCEL Avita Medical Inc. Reduce -90.3% 0.38% −0.80 PODD Insulet Corp. Sold out 0.00% −0.65 EVH Evolent Health Inc. Class A Sold out 0.00% −0.51 SOPH Sophia Genetics SA Sold out 0.00% −0.32 DVA Davita Inc. Sold out 0.00% −0.31 CHWY Chewy Inc. Class A Sold out 0.00% −0.23 NYXH Nyxoah SA Sold out 0.00% −0.12 APYX Apyx Medical Corp. Sold out 0.00% −0.05 MYGN Myriad Genetics Inc. Reduce -10.6% 0.65% +0.42 IMDX Insight Molecular Diagnostic Reduce -10.7% 1.05% +0.70 ELAN Elanco Animal Health Inc. Reduce -16.0% 2.14% +1.32 LUNG Pulmonx Corp. Reduce -2.2% 2.95% +1.49 QTRX Quanterix Corp. Reduce -42.3% 6.03% +1.78 LIVN Livanova PLC Reduce -30.6% 3.43% +1.83 NTRA Natera Inc. Reduce -23.0% 4.46% +3.07 ESTA Establishment Labs Holdings Reduce -37.4% 9.07% +6.49
Portfolio Buys Q4 2023 → Q1 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q4 2023 % Of Portfolio Change To Portfolio ▼ EXAS Exact Sciences Corp. New 22.66% +22.66 ISRG Intuitive Surgical Inc. New 6.54% +6.54 GKOS Glaukos Corp. New 5.07% +5.07 MSOS Advisorshares Pure US Cann Add +225.3% 3.95% +3.66 MGX Metagenomi Therapeutics Inc. New 3.31% +3.31 VKTX Viking Therapeutics Inc. New 2.23% +2.23 DXCM Dexcom Inc. Add +14.7% 2.83% +2.06 SWAV Shockwave Medical Inc. New 1.94% +1.94 ATEC Alphatec Holdings Inc. Add +4.9% 3.01% +1.91 INSP Inspire Medical Systems Inc. Add +50.0% 2.19% +1.71 RGEN Repligen Corp. New 1.41% +1.41 GH Guardant Health Inc. Add +566.7% 1.40% +1.31 TNDM Tandem Diabetes Care Inc. New 1.02% +1.02 EW Edwards Lifesciences Corp. New 1.00% +1.00 TXG 10X Genomics Inc. Class A New 0.97% +0.97 BAX Baxter International Inc. New 0.87% +0.87 ZIMV Zimvie Inc. New 0.82% +0.82 TMCI Treace Medical Concepts Inc. New 0.80% +0.80 CUTRQ Cutera Inc. Add +0.8% 1.08% +0.18
Options Activity Q4 2023 → Q1 2024 Security Type Change vs Q4 2023 Underlying Shares Value ▼ ISHARES TR put New 705,000 $148.3M HUMANA INC call New 175,000 $60.7M STATE STR SPDR S&P 500 ETF T put New 80,000 $41.8M ISHARES TR put New 659,000 $38.6M ACWX iShares MSCI Acwi Ex US ETF put Sold out 650,000 $35.1Mbefore exit EXACT SCIENCES CORP call New 495,100 $34.2M SPDR SERIES TRUST put New 340,000 $32.3M SPY SS SPDR S&P 500 ETF Trust-US put Sold out 57,500 $27.3Mbefore exit INVESCO QQQ TR put New 60,000 $26.6M ADVISORSHARES TR call Sold out 3,200,000 $22.4Mbefore exit IXP iShares Global Comm Services put Sold out 102,500 $20.6Mbefore exit QQQ Invesco QQQ Trust Series 1 put Sold out 50,000 $20.5Mbefore exit UNH Unitedhealth Group Inc. put Sold out 34,000 $17.9Mbefore exit GKOS Glaukos Corp. call Sold out 178,500 $14.2Mbefore exit ISRG Intuitive Surgical Inc. call Sold out 35,000 $11.8Mbefore exit ARK ETF TR put New 400,000 $11.5M XITK SS SPDR F Inno Tech ETF put Sold out 120,000 $10.7Mbefore exit ADVISORSHARES TR call New 950,000 $9.5M LIVANOVA PLC call New 145,400 $8.1M ARKK ARK Innovation ETF put Sold out 150,000 $7.9Mbefore exit ARK ETF TR put New 150,000 $7.5M GUARDANT HEALTH INC call New 323,300 $6.7M ARKG ARK Genomic Revolution ETF put Sold out 200,000 $6.6Mbefore exit SYK Stryker Corp. put Sold out 20,000 $6.0Mbefore exit RESMED INC put New 28,000 $5.5M BAUSCH HEALTH COS INC call New 400,000 $4.2M INSP Inspire Medical Systems Inc. call Sold out 20,000 $4.1Mbefore exit INMD Inmode Ltd. put Sold out 175,000 $3.9Mbefore exit ILMN Illumina Inc. call Sold out 27,900 $3.9Mbefore exit BAX Baxter International Inc. call Sold out 100,000 $3.9Mbefore exit INSPIRE MED SYS INC put New 17,500 $3.8M LNTH Lantheus Holdings Inc. call Sold out 60,200 $3.7Mbefore exit INSPIRE MED SYS INC call New 15,000 $3.2M NTRA Natera Inc. call Sold out 48,200 $3.0Mbefore exit GH Guardant Health Inc. call Sold out 100,000 $2.7Mbefore exit STAA Staar Surgical Co. put Sold out 77,500 $2.4Mbefore exit INTUITIVE SURGICAL INC call New 6,000 $2.4M TNDM Tandem Diabetes Care Inc. call Sold out 75,000 $2.2Mbefore exit QTRX Quanterix Corp. call Sold out 80,000 $2.2Mbefore exit LIVN Livanova PLC call Sold out 29,700 $1.5Mbefore exit INMODE LTD put New 61,600 $1.3M ESTA Establishment Labs Holdings call Sold out 50,000 $1.3Mbefore exit CUTRQ Cutera Inc. call Sold out 200,000 $705Kbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q4 2023 → Q1 2024 Security Class Change vs Q4 2023 Shares / Principal Value ▼ SOMALOGIC INC *W EXP 08/31/202 Sold out 173,876 $21Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 19 $37.0M ALMR, BBNX, ESTA, IMDX, NVDA Q1 2026 17 $14.9M IMDX, BBNX, ESTA, CAI, NSPR Q4 2025 18 $26.8M BBNX, IMDX, ESTA, CAI, NSPR Q3 2025 8 $16.4M BBNX, IMDX, CAI, ESTA, NSPR Q2 2025 8 $16.6M BBNX, IMDX, CAI, ESTA, OM Q1 2025 8 $13.7M BBNX, IMDX, ESTA, NSPR, KMTS Q4 2024 9 $18.1M ESTA, MSOS, LUNG, QTRX, IMDX Q3 2024 16 $60.8M MSOS, ESTA, GKOS, NTRA, ISRG Q2 2024 25 $82.7M ESTA, GKOS, ISRG, NTRA, MSOS Q1 2024 30 $146.8M EXAS, ESTA, ISRG, QTRX, LYRA